Atlas Trials

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

Clinical trial NCT05873712 · RECRUITING

Trial details

NCT number
NCT05873712
Sponsor
Aseel Alsouqi
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaTransformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell LymphomaRecurrent Transformed B-Cell Non-Hodgkin LymphomaRecurrent Transformed Non-Hodgkin LymphomaRefractory Transformed Non-Hodgkin LymphomaRefractory Transformed B-cell Non-Hodgkin LymphomaRefractory Transformed
Start date
2023-07-28
Primary completion
2026-12-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.